Embedded teeth, including avohilmo

K11_EMBED_TEETH

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — K01.0 Hospital discharge: ICD-10 — K01.0 Cause of death: ICD-10 — K01.0 3 out of 7 registries used, show all original rules.	4188
4. Check minimum number of events None	4188
5. Include endpoints None	4188
6. Filter based on genotype QC (FinnGen only)	4188

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF10

NAME	K11_EMBED_TEETH
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD	K010
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K010
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K010
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Embedded teeth, including avohilmo based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	41806	23958	17720
Only index persons	40280	23276	17004
Unadjusted period prevalence (%)
Whole population	0.60	0.69	0.50
Only index persons	0.77	0.86	0.65
Median age at first event (years)
Whole population	23.49	23.48	23.45
Only index persons	23.68	23.67	23.68

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4188	2922	1266
Unadjusted period prevalence (%)	0.86	1.00	0.56
Median age at first event (years)	27.64	26.38	30.54

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3532: Matched controls
35322

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

K01.0

ICD-10 Finland

Embedded teeth

+∞

323.0

3532

EBA10

NOMESCO Finland

Surgical removal of tooth

9.9

323.0

2112

4621

EBA12

NOMESCO Finland

Complicated surgical removal of tooth

8.2

248.6

601

864

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

3.2

225.8

2140

11572

SAA03

NOMESCO Finland

Extended examination of mouth

2.4

132.6

1971

12181

SXB00

NOMESCO Finland

Removeal of sutres from oral mucosa

4.6

128.2

485

1172

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

5.9

126.9

382

713

K05.32

ICD-10 Finland

Periodontitis NOS

3.0

121.7

842

3332

ECA00

NOMESCO Finland

Surgical exposure of tooth

23.9

101.8

147

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.2

95.8

1398

8119

WZB00

NOMESCO Finland

Telephone receipt or other advice

2.2

95.2

1385

8021

WZA90

NOMESCO Finland

Other doctors statement

2.2

84.6

1121

6145

WX290

NOMESCO Finland

Other blockade of nerve

2.0

81.8

2137

15387

SAA01

NOMESCO Finland

Simple examination of mouth

2.2

78.5

2812

22758

SAA02

NOMESCO Finland

Basic examination of mouth

2.1

78.3

2781

22404

WX110

NOMESCO Finland

Local anesthesy

2.0

67.1

2669

21577

EFA50

NOMESCO Finland

Excision of cyst of jaws

13.6

60.2

106

EB1AI

NOMESCO Finland

Cone beam imaging of teeth and jaws (one quarter)

7.1

58.7

148

215

EBA00

NOMESCO Finland

Extraction of tooth

1.8

56.4

1401

9414

K09.03

ICD-10 Finland

Cyst eruption

25.2

56.0

SAA04

NOMESCO Finland

Special inverstigation of mouth

3.0

55.6

353

1268

SJD00

NOMESCO Finland

Removal or reattacment of arrow in fixed orthodontisk device

3.2

50.1

278

907

EDC10

NOMESCO Finland

Sagittal osteotomy of ramus of mandible

9.7

49.2

102

108

SBB10

NOMESCO Finland

Teeth copy

2.4

49.0

454

2029

K07.13

ICD-10 Finland

Retrognaty, mandibular

5.3

48.5

153

297

SJD10

NOMESCO Finland

Attachment of arrow to fixed orthodontisk device

3.1

46.9

274

927

SBB00

NOMESCO Finland

Fotograf of mouth and teeth

3.2

46.8

259

843

Z01.2

ICD-10 Finland

Dental examination

1.7

46.3

1668

12301

SJD20

NOMESCO Finland

Attachment of modifiable arrow of fixed orthodontisk device

3.5

43.9

220

664

EMAK

NOMESCO Finland

3.3

43.2

229

722

J01CE02

ATC

phenoxymethylpenicillin; oral

1.7

41.9

2629

22288

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.7

41.6

301

1168

SJC01

NOMESCO Finland

Positioning and fixed attachment of single bracket (Bracket with fixed attachment)

3.1

39.6

226

751

SJC50

NOMESCO Finland

Removal of orthodontisk device with at least 7 brackets

3.0

39.0

235

810

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

2.3

38.8

393

1824

KMAK

NOMESCO Finland

1.6

38.3

1944

15372

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

6.0

37.6

106

180

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

36.6

1761

13676

K02.1

ICD-10 Finland

Caries of dentine

1.6

34.2

2233

18519

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.8

33.6

229

855

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.5

33.1

1865

14885

127

Kela drug reimbursment

Transplant complication

6.3

31.6

140

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.2

31.4

355

1728

SJC10

NOMESCO Finland

Orthodontic bandage in one tooth

3.2

31.4

170

544

SJX10

NOMESCO Finland

Short check-up visit for orthodontisk therapy

2.2

30.9

340

1636

K07.35

ICD-10 Finland

Impacted or embedded teeth with abnormal position of such teeth or adjacent teeth

5.7

29.4

154

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.9

29.2

481

2715

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.5

28.6

2153

18040

EEC05

NOMESCO Finland

Le Fort I osteotomy

10.0

27.9

K01.1

ICD-10 Finland

Impacted teeth

4.3

27.9

105

248

K03.64

ICD-10 Finland

Dental calculus supragingival

1.5

27.8

1148

8419

-1

NOMESCO Finland

1.5

27.7

1450

11209

SXC03

NOMESCO Finland

Other oral or dental procedure

6.5

27.5

112

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.5

27.4

1970

16268

SJD30

NOMESCO Finland

Demanding attachment of arrow to fixed orthodontisk device

3.2

26.8

144

459

K01.17

ICD-10 Finland

Retained molar with obstruction in the lower jaw

2.5

26.5

217

900

SJD40

NOMESCO Finland

Fixation of ready made palatinal or lingual arrow

2.6

25.8

196

780

Z94.0

ICD-10 Finland

Kidney transplant status

6.7

25.3

L04AA06

ATC

mycophenolic acid; systemic

5.0

25.1

168

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.5

25.0

1198

9030

SDA02

NOMESCO Finland

Parodonthologic therapy

1.5

24.5

1144

8562

SJC00

NOMESCO Finland

Bracket with fixed attachment

8.8

24.2

SJB00

NOMESCO Finland

Fitting of loose orthodontic device with user information

2.4

24.2

208

885

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

23.8

595

3816

EBB10

NOMESCO Finland

Insertion of dental implant

5.3

23.8

139

K07.30

ICD-10 Finland

Spacing, abnormal of tooth or teeth

2.5

23.8

193

795

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

2.0

23.6

318

1660

J01FF01

ATC

clindamycin; systemic

1.6

23.6

748

5107

SJC03

NOMESCO Finland

Positioning and fixed attachment of brackets, extensive

2.8

23.3

158

587

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.5

23.2

1054

7823

L04AA01

ATC

[U] ciclosporin; systemic

5.8

23.2

115

K00.00

ICD-10 Finland

Hypodontia

3.7

23.2

103

284

K01.12

ICD-10 Finland

Retained canine with obstruction in the upper jaw

9.1

22.0

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

7.9

21.9

SXC05

NOMESCO Finland

Other oral or dental procedure

2.0

21.6

286

1481

EB1MA

NOMESCO Finland

Cephalometry with X-ray

2.5

21.6

179

746

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.4

21.3

1976

16747

D19

ICPC

Teeth/gum symptom/complaint

1.5

21.3

958

7069

WZA00

NOMESCO Finland

Short statement of of health and health related matters

2.1

20.7

256

1289

SJC02

NOMESCO Finland

Positioning and fixed attachment of brackets

2.9

20.6

130

463

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

4.8

20.2

145

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

1.5

20.1

744

5248

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.9

19.8

329

1854

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

9.0

19.6

SBB20

NOMESCO Finland

Tooth X-ray examination in conjunction with visit to dentist

5.4

19.4

108

ECB00

NOMESCO Finland

Suture of gingiva

2.8

19.4

127

464

K07.24

ICD-10 Finland

Open bite

3.4

19.3

286

M01AE01

ATC

ibuprofen; systemic, rectal

1.6

19.1

3069

28554

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

4.8

19.1

136

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

18.9

1219

9606

K01.10

ICD-10 Finland

Retained front tooth with obstruction in the upper jaw

23.8

18.6

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

18.3

709

5039

K05.22

ICD-10 Finland

Acute pericoronitis

1.7

18.3

377

2278

EB1WA

NOMESCO Finland

7.3

17.7

K01.19

ICD-10 Finland

Retained tooth with obstruction barrier UNS

12.5

17.6

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.2

17.5

192

918

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

17.5

1137

8943

WX704

NOMESCO Finland

Intubation

2.1

17.3

209

1041

K07.10

ICD-10 Finland

Asymmetry of jaw

7.3

17.2

SJA04

NOMESCO Finland

Very demanding plan for orthodontic care

8.5

17.2

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.5

16.8

704

5077

K00.7

ICD-10 Finland

Teething syndrome

2.0

16.7

232

1226

SJX21

NOMESCO Finland

Therapeutic intervention or check-up related to orthodontic treatment

2.3

16.5

152

672

K07.60

ICD-10 Finland

Snapping jaw

2.0

16.4

217

1122

137

Kela drug reimbursment

Uraemia requiring dialysis

7.0

16.4

K05.30

ICD-10 Finland

Periodontitis complex

1.9

16.1

262

1464

K10.3

ICD-10 Finland

Alveolitis of jaws

2.1

16.0

193

966

SPC20

NOMESCO Finland

Attachment of crone of tooth to implant

5.5

15.8

A11CC03

ATC

alfacalcidol; systemic

3.7

15.8

190

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

5.1

15.6

A12AA04

ATC

calcium carbonate; oral

4.8

15.5

107

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.4

15.5

809

6083

SJC40

NOMESCO Finland

Removal of orthodontisk device with at most 6 brackets

2.2

15.5

159

741

SJA03

NOMESCO Finland

Demanding plan for orthodontic care

9.0

15.4

K12.2

ICD-10 Finland

Cellulitis and abscess of mouth

4.5

15.2

119

A02BC05

ATC

esomeprazole; systemic

1.4

15.1

901

6939

K00.68

ICD-10 Finland

Other disturbance in the tooth eruption

2.7

15.1

101

375

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.2

15.0

155

723

K07.1

ICD-10 Finland

Anomalies of jaw-cranial base relationship

10.8

15.0

B05DA

ATC

Isotonic solutions

7.9

14.8

N02BE01

ATC

paracetamol; systemic, rectal

1.4

14.7

2557

23259

VALMI

NOMESCO Finland

1.4

14.7

1007

7938

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

7.5

14.7

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.5

14.6

471

3197

K01.16

ICD-10 Finland

Retained molar with obstruction in the upper jaw

2.6

14.4

105

412

Z49.2

ICD-10 Finland

Other dialysis

7.1

14.3

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.8

14.1

268

1572

K01

ICD-10 Finland

Embedded and impacted teeth

3.3

14.1

219

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.5

14.1

565

4025

EBB15

NOMESCO Finland

Insertion of dental implant abutment

5.3

14.0

P01AB01

ATC

metronidazole; oral, rectal

1.4

14.0

1061

8489

ZXA00

NOMESCO Finland

Right side

1.5

13.8

498

3465

N02AX02

ATC

tramadol; systemic, rectal

1.4

13.8

884

6878

SJX11

NOMESCO Finland

Therapeutic intervention or check-up related to orthodontic treatment, restricted

2.0

13.7

182

943

K07.14

ICD-10 Finland

Retrognaty, maxillary

5.0

13.6

N03AX12

ATC

gabapentin; oral

1.6

13.6

327

2061

WX002

NOMESCO Finland

Sedation and analgesia

1.6

13.4

409

2734

Z49.1

ICD-10 Finland

Extracorporeal dialysis

4.9

13.4

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.3

13.3

124

554

Z54.0

ICD-10 Finland

Convalescence following surgery

3.1

13.3

230

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.3

13.2

1226

10098

SJX20

NOMESCO Finland

Check-up visit for orthodontisk therapy

2.0

13.1

164

832

ZXA10

NOMESCO Finland

Bilateral

1.5

13.0

415

2806

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

2.1

13.0

144

695

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

13.0

473

3294

K07.23

ICD-10 Finland

Deep bite

2.1

12.9

138

656

K09.09

ICD-10 Finland

Odontogenic developmental cyst UNS

22.6

12.9

Z49.0

ICD-10 Finland

Preparatory care for dialysis

6.1

12.8

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.3

12.7

L04AD01

ATC

ciclosporin; systemic

3.2

12.6

211

TK800

NOMESCO Finland

Hemodialysis

3.6

12.5

159

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

12.4

1023

8261

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.3

12.2

1008

8138

N18.0

ICD-10 Finland

End-stage renal disease

5.9

11.8

J01DB01

ATC

cefalexin; oral

1.3

11.7

2654

24560

K07.25

ICD-10 Finland

Anomalies of dental arch relationship

2.4

11.4

387

G50.1

ICD-10 Finland

Atypical facial pain

3.3

11.4

166

WX720

NOMESCO Finland

Own respiration

2.3

11.0

436

SXC02

NOMESCO Finland

Other oral or dental procedure, restricted

2.3

11.0

425

ZXA05

NOMESCO Finland

Left side

1.5

10.9

452

3230

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.6

10.9

293

1900

B05DB

ATC

Hypertonic solutions

6.9

10.8

XMA20

NOMESCO Finland

Early examination of pregnancy

2.8

10.8

246

EB1BD

NOMESCO Finland

Extensive cone beam CT of teeth and jaws (two quarters)

11.9

10.8

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

5.4

10.7

D82

ICPC

Teeth/gum disease

1.3

10.6

1237

10430

EFB40

NOMESCO Finland

Removal of internal or external fixation device from facial bones

5.7

10.5

C03CA01

ATC

furosemide; systemic

1.6

10.5

294

1922

A02BC03

ATC

lansoprazole; oral

1.4

10.3

530

3946

SAC03

NOMESCO Finland

Separate planning of oral and dental treatment, very demanding

4.0

10.3

102

K01.14

ICD-10 Finland

Retained premolar with obstruction in the upper jaw

18.8

10.2

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

10.2

493

3627

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.1

10.2

118

582

SPAT1324

SPAT

Screening procedure

1.4

10.2

550

4130

K02.0

ICD-10 Finland

Caries limited to enamel

1.4

10.1

615

4710

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

9.8

160

898

K05.39

ICD-10 Finland

Periodontitis UNS

3.5

9.8

127

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.3

9.8

388

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.3

9.7

358

TK820

NOMESCO Finland

Peritoneal dialysis

7.4

9.7

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.5

9.7

357

2488

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

9.6

551

4177

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

7.8

9.6

KAY40

NOMESCO Finland

1.7

9.6

194

1166

SMAK

NOMESCO Finland

3.9

9.6

SJB60

NOMESCO Finland

External device grinding and adaptation

2.0

9.5

112

559

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

9.5

1107

9310

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

9.5

1032

8600

SAC02

NOMESCO Finland

Separate planning of oral and dental treatment, demanding

2.2

9.5

402

J02AC01

ATC

fluconazole; systemic

1.3

9.5

1140

9625

N03AX16

ATC

pregabalin; oral

1.4

9.4

449

3295

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.4

9.4

325

R4110

NOMESCO Finland

Physiotherapy

1.4

9.4

570

4365

ECB15

NOMESCO Finland

Plastic repair of oronasal or oroantral fistula

5.8

9.3

SAC01

NOMESCO Finland

Separate planning of oral and dental treatment, standard

2.0

9.3

114

579

K03.66

ICD-10 Finland

Tooth plaque

1.7

9.2

198

1213

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

9.1

220

1387

H02AB04

ATC

methylprednisolone; systemic

1.5

9.0

282

1893

K03.30

ICD-10 Finland

Internal granuloma of pulp

5.9

9.0

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

9.0

393

2834

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.3

9.0

696

5524

EBB11

NOMESCO Finland

Insertion of additional dental implant in one session

5.6

9.0

B03XA02

ATC

darbepoetin alfa; parenteral

3.6

9.0

105

SJA01

NOMESCO Finland

Estimation of need for orthodontic care

5.2

8.9

TJW99

NOMESCO Finland

Other minor procedure in gastrointestinal endoscopy

12.5

8.9

R50.9

ICD-10 Finland

Fever, unspecified

1.4

8.8

393

2845

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.0

8.8

161

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.5

8.7

257

KAY20

NOMESCO Finland

1.8

8.6

157

912

Z94.4

ICD-10 Finland

Liver transplant status

6.6

8.6

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.9

8.6

174

B03XA01

ATC

erythropoietin; parenteral

5.2

8.6

K07.04

ICD-10 Finland

Macrognathism (mandibular)(maxillary)

11.6

8.6

J01MA02

ATC

ciprofloxacin; systemic

1.3

8.5

794

6467

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

8.5

344

2441

V03AE02

ATC

sevelamer; oral

7.3

8.4

J01EA01

ATC

trimethoprim; systemic

1.3

8.4

617

4854

K08.3

ICD-10 Finland

Retained dental root

1.8

8.4

133

741

N18.8

ICD-10 Finland

Other chronic renal failure

3.2

8.4

128

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

7.9

8.3

K05.31

ICD-10 Finland

Periodontitis pronounced

1.7

8.3

153

895

TPH07

NOMESCO Finland

Cathetrisation of artery

1.7

8.3

172

1042

R51.80

ICD-10 Finland

Headache

1.4

8.3

503

3844

H02AB06

ATC

prednisolone; systemic

1.3

8.2

1093

9303

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

3.9

8.1

A02BC02

ATC

pantoprazole; systemic

1.2

8.1

1492

13161

K09.00

ICD-10 Finland

Cyst dentigerous

33.4

8.1

SJD50

NOMESCO Finland

Production and attachment of palatinal or lingual arrow

2.8

8.0

172

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.3

8.0

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

1.9

8.0

112

598

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

7.9

282

1951

EB1AD

NOMESCO Finland

Cone beam CT of teeth and jaws (one quarter)

4.9

7.9

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prothetic work

2.2

7.8

365

WX725

NOMESCO Finland

Noninvasive ventilation

1.9

7.8

109

584

EWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of teeth, jaws, mouth and pharynx

10.8

7.8

SPAT1044

SPAT

Tympanometry

2.2

7.7

347

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

7.7

198

1271

A12AA12

ATC

[U] calcium acetate anhydrous; systemic

15.0

7.7

WX872

NOMESCO Finland

Intensive care

2.2

7.7

360

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.4

7.6

370

2722

M79.1

ICD-10 Finland

Myalgia

1.4

7.6

350

2550

N05BA01

ATC

diazepam; systemic, rectal

1.5

7.6

278

1938

C02CA01

ATC

prazosin; oral

4.5

7.5

H05BX01

ATC

cinacalcet; oral

8.9

7.5

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

10.0

7.5

L03

ICPC

Low back symptom/complaint

1.3

7.5

683

5535

OIKK

NOMESCO Finland

1.6

7.5

172

1073

K08.80

ICD-10 Finland

Toothache NOS

1.5

7.5

245

1664

F45.8

ICD-10 Finland

Other somatoform disorders

1.5

7.4

273

1902

A28

ICPC

Limited function/disability NOS

1.6

7.4

166

1027

UJF32

NOMESCO Finland

Coloscopy

1.4

7.4

430

3265

KAY60

NOMESCO Finland

2.0

7.4

480

S18

ICPC

Laceration/cut

1.3

7.4

926

7810

196

Kela drug reimbursment

Paricalcitol and cinacalcet

6.0

7.4

K05.18

ICD-10 Finland

Chronic gingivitis

1.7

7.4

159

978

SJA02

NOMESCO Finland

Plan for orthodontic care

6.8

7.3

K05.33

ICD-10 Finland

Thickened dental follicle

15.8

7.2

M79.6

ICD-10 Finland

Pain in limb

1.3

7.2

861

7216

C07AB07

ATC

bisoprolol; oral

1.3

7.2

662

5367

XPX08

NOMESCO Finland

Intraoperative flow measurement

5.8

7.2

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

7.2

410

3103

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.6

7.1

196

M54.5

ICD-10 Finland

Low back pain

1.3

7.1

883

7435

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

4.0

7.1

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

8.8

7.0

Z29.8

ICD-10 Finland

Other specified prophylactic measures

2.0

7.0

413

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

7.0

223

1512

SDA05

NOMESCO Finland

Very demanding and lengthy parodonthologic therapy

1.7

6.9

131

775

EBA12

SPAT

8.3

6.8

K07.18

ICD-10 Finland

Another anomaly in the relationship between jaw and skull base

6.7

6.8

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

6.7

1737

15746

J01DA01

ATC

[U] cefalexin; systemic

1.2

6.7

1739

15764

S02.66

ICD-10 Finland

Fracture of the angulus mandipulae

22.5

6.7

J01AA02

ATC

doxycycline; systemic

1.2

6.6

1906

17446

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

6.4

6.6

H13

ICPC

Plugged feeling ear

1.4

6.6

317

2329

K09.08

ICD-10 Finland

Another edontogenic developmental cyst

12.3

6.6

ECB40

NOMESCO Finland

Surgical treatment of fracture of alveolus

4.0

6.6

ZX120

NOMESCO Finland

Intravenous

1.5

6.5

184

1213

WYA50

NOMESCO Finland

Student oral health check consistent with decree to assess need for oral health guidance and services

1.5

6.5

225

1550

K07.4

ICD-10 Finland

Malocclusion, unspecified

2.2

6.5

278

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

6.5

283

2041

SJE90

NOMESCO Finland

Finishing face of orthodontick therapy

3.7

6.5

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

2.0

6.5

376

M48.0

ICD-10 Finland

Spinal stenosis

1.7

6.4

114

661

J01FA06

ATC

roxithromycin; oral

1.2

6.4

930

7952

L17

ICPC

Foot/toe symptom/complaint

1.3

6.4

617

5032

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

4.1

6.4

N03AX11

ATC

topiramate; oral

1.9

6.4

436

A07AA02

ATC

nystatin; oral

1.8

6.3

547

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

3.6

6.3

K07.11

ICD-10 Finland

Retrognathism (mandibular)(maxillary)

3.7

6.3

K09.02

ICD-10 Finland

Cyst lateral periodontal

18.0

6.3

SJB10

NOMESCO Finland

Fitting of loose orthodontic device with user information, demanding

2.2

6.2

274

K09.29

ICD-10 Finland

Cyst of jaw traumatic

6.3

6.2

K06.18

ICD-10 Finland

Another gingival hyperplasia

5.3

6.1

7143C

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[POLYARTHRITIS JUVENILIS SERONEGATIVA]

7.7

6.1

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.1

6.1

288

L01

ICPC

Neck symptom/complaint

1.3

6.1

373

2853

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.3

6.1

515

4124

K01.15

ICD-10 Finland

Retained premolar with obstruction in the lower jaw

12.5

6.1

V03AE03

ATC

lanthanum carbonate; oral

8.6

6.0

EDC30

NOMESCO Finland

Genioplasty

10.0

6.0

N03AG01

ATC

valproic acid; systemic, rectal

1.6

6.0

158

1025

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.4

6.0

263

1900

M08.3

ICD-10 Finland

Juvenile polyarthritis (seronegative)

3.0

6.0

103

SDE04

NOMESCO Finland

Periodontal treatment by dental hygienist, very extensive

1.4

6.0

230

1622

C08CA02

ATC

felodipine; oral

1.9

6.0

466

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

238

1086

2.26

29.19

2.1

1.9

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

372

2064

1.88

26.78

2.3

2.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

133

4.64

26.12

30.4

26.1

ug/l

108.3

135.6

1.11

112

(3047181) Lactate [Moles/volume] in Blood

164

668

2.51

25.96

4.8

6.6

mmol/l

1.3

1.2

0.37

141

588

(3019150) Specific gravity of Urine by Refractometry

1017

7500

1.47

23.31

3.9

3.2

kg/l

1.0

1.75

146

1105

(3026250) Tacrolimus [Mass/volume] in Blood

154

4.07

22.52

37.0

37.9

ug/l

7.2

7.3

0.20

141

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

150

652

2.35

20.64

7.3

5.4

iu/ml

685.3

781.1

0.09

(42870588) Differential panel, method unspecified - Blood

1297

10337

1.37

18.29

7.0

6.0

—

(3039000) Anion gap in Blood

107

430

2.53

17.52

5.4

8.6

mmol/l

10.9

11.5

0.71

390

(3018572) Chloride [Moles/volume] in Blood

107

431

2.52

17.43

5.4

8.6

mmol/l

104.9

105.5

0.67

391

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

117

499

2.38

16.86

4.1

3.2

u/ml

1566.8

1820.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

194

1015

1.96

16.63

8.1

11.0

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1455

11935

1.34

16.60

8.8

5.8

mmol/l

1.2

0.02

1261

10123

(3024561) Albumin [Mass/volume] in Serum or Plasma

1316

10651

1.34

16.39

6.2

4.6

g/l

36.8

37.0

0.90

1242

9917

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

224

1239

1.85

16.22

3.3

2.8

ng/l

128.6

126.3

0.04

201

1078

(3022096) Basophils/100 leukocytes in Blood

1738

14717

1.31

15.52

7.0

6.0

0.6

0.7

0.71

1644

13798

(3013707) Erythrocyte sedimentation rate by Westergren method

2568

22918

1.31

15.51

4.3

3.6

mm/h

8.9

8.7

0.45

2443

21407

(3019198) Lymphocytes [#/volume] in Blood

1971

16977

1.30

15.50

6.8

5.8

e9/l

2.0

0.00

1809

15273

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

547

3844

1.49

15.37

2.0

1.7

—

(3018010) Neutrophils/100 leukocytes in Blood

1862

15983

1.30

14.76

6.6

5.6

55.8

56.0

0.28

1769

15093

(3002030) Lymphocytes/100 leukocytes in Blood

1884

16201

1.30

14.71

6.8

5.8

30.3

30.1

0.27

1784

15255

(3013115) Eosinophils [#/volume] in Blood

1945

16803

1.29

14.63

7.3

6.2

e9/l

0.2

3.63

1782

15046

(3008152) Bicarbonate [Moles/volume] in Arterial blood

204

1133

1.84

14.60

6.4

7.6

mmol/l

24.6

24.1

0.96

184

1060

(3001604) Monocytes [#/volume] in Blood

1878

16171

1.29

14.41

6.9

5.9

e9/l

0.5

0.94

1689

14260

(3006315) Basophils [#/volume] in Blood

1882

16219

1.29

14.31

7.0

5.9

e9/l

0.0

0.35

1695

14287

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.87

14.25

4.6

5.7

—

(3006504) Eosinophils/100 leukocytes in Blood

1783

15285

1.29

14.03

6.9

5.9

2.6

2.8

2.99

1695

14311

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

4.14

13.91

3.5

2.6

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2113

18529

1.28

13.83

9.7

8.2

e9/l

3.9

4.0

0.92

1903

16312

(3019069) Monocytes/100 leukocytes in Blood

1787

15390

1.28

13.33

7.2

6.1

8.2

8.1

1.59

1701

14519

(3003396) Base excess in Arterial blood by calculation

324

2108

1.58

12.94

7.6

8.1

mmol/l

1.0

0.8

0.47

239

1588

(3023368) Bacteria identified in Blood by Culture

784

6048

1.36

12.89

5.0

3.8

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1084

8810

1.31

12.42

2.9

2.4

u/l

58.2

55.7

0.37

1014

8153

(3016502) Oxygen saturation in Arterial blood

289

1849

1.60

12.39

8.0

8.7

96.6

96.3

0.32

267

1787

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

368

2489

1.52

12.35

1.9

1.6

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1282

10706

1.28

11.84

8.0

5.4

mmol/l

1.2

0.12

1185

9785

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

560

4140

1.41

11.84

3.4

2.9

ng/l

663.5

449.0

0.44

317

2255

(3019060) Gas panel - Arterial blood

196

1147

1.74

11.82

4.7

5.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

272

1738

1.60

11.73

1.9

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

370

2535

1.50

11.68

2.0

1.7

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

272

1742

1.60

11.62

8.2

9.0

g/l

120.0

124.1

2.62

254

1684

(3026008) Bacteria identified in Urine by Culture

1075

8808

1.30

11.44

2.6

2.3

—

(3042936) Bacteria identified in Isolate by Culture

507

3711

1.42

11.33

2.2

1.9

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1596

13749

1.26

11.27

6.5

5.1

umol/l

10.1

10.4

0.78

1502

12860

(3042733) HLA Ab [Presence] in Serum

107

3.48

10.97

5.7

4.7

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

138

744

1.88

10.92

4.8

6.2

1.0

0.9

0.36

123

694

(3007853) Bacteria identified in Skin by Aerobe culture

492

3611

1.41

10.81

1.8

1.6

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

919

7440

1.30

10.59

3.8

3.1

—

(3037467) Urinalysis macro (dipstick) panel - Urine

2540

23159

1.25

10.48

4.7

3.8

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

311

2112

1.51

10.24

7.6

8.1

kpa

5.1

5.0

0.19

292

2030

(3018677) aPTT in Platelet poor plasma by Coagulation assay

489

3628

1.39

10.06

2.7

2.4

29.5

29.3

0.23

470

3505

(3027801) Oxygen [Partial pressure] in Arterial blood

310

2112

1.51

10.05

7.6

8.1

kpa

13.3

13.5

0.39

292

2031

(3000034) Microalbumin [Mass/volume] in Urine

183

2.75

10.01

3.1

mg/l

50.7

31.8

0.22

134

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2409

21894

1.24

9.99

8.2

6.3

u/l

74.8

73.2

0.67

2296

20599

(3018418) pH of Serum or Plasma

856

6913

1.30

9.98

6.0

3.5

7.4

0.77

142

1360

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

103

524

1.99

9.71

1.5

mmol/l

10.0

11.8

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

492

3677

1.38

9.68

2.9

2.2

g/l

2.5

0.38

463

3396

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3604

34397

1.34

9.66

13.2

9.9

mg/l

19.9

20.4

0.36

2838

26079

(3015377) Calcium [Moles/volume] in Serum or Plasma

1012

8395

1.27

9.48

3.3

2.8

mmol/l

2.3

1.06

923

7558

(3015736) pH of Urine

1501

13057

1.23

9.17

3.5

2.9

—

5.8

—

(3032080) INR in Blood by Coagulation assay

1050

8781

1.26

9.14

7.5

5.5

inr

1.1

0.20

354

3027

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1155

9789

1.25

8.91

1.7

pmol/l

100.0

97.9

0.85

626

5437

(3005719) IgG [Mass/volume] in Serum or Plasma

346

2467

1.44

8.91

2.5

g/l

10.2

10.5

0.94

329

2269

(3023103) Potassium [Moles/volume] in Serum or Plasma

3357

31813

1.28

8.90

13.5

9.8

mmol/l

3.9

3.77

3258

30706

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

131

743

1.79

8.88

4.3

6.2

1.9

1.7

0.77

116

692

(3013826) Glucose [Moles/volume] in Serum or Plasma

1878

16761

1.22

8.82

5.4

4.2

mmol/l

6.3

6.2

0.52

1671

14902

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1239

10607

1.24

8.68

4.2

3.0

u/l

31.9

29.2

1.39

1185

10113

(3019550) Sodium [Moles/volume] in Serum or Plasma

3347

31735

1.27

8.65

13.2

9.7

mmol/l

139.3

139.5

4.63

3255

30714

(3031040) Bacteria [#/volume] in Urine by Automated count

2422

22197

1.22

8.60

4.6

3.8

e6/l

4092.9

1948.8

0.25

255

(3022948) Iron [Moles/volume] in Serum or Plasma

529

4073

1.34

8.58

2.8

2.2

umol/l

14.2

14.7

0.90

498

3765

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

826

6759

1.28

8.55

2.2

2.1

u/l

196.0

196.3

0.00

787

6409

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

443

3321

1.37

8.53

3.0

2.3

22.9

24.3

1.44

369

2869

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

113

621

1.84

8.50

1.3

1.4

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

905

7503

1.26

8.39

2.2

2.1

mg/l

2.5

2.7

2.39

808

6431

(36660697) Celiac disease serology panel - Serum

463

3515

1.36

8.23

1.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

482

3702

1.34

7.93

5.2

3.7

mmol/l

0.8

2.20

451

3484

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

226

1517

1.52

7.91

6.6

4.2

ng/l

92.4

74.9

1.83

216

1378

(3035350) Ketones [Presence] in Urine by Test strip

1861

16721

1.20

7.81

3.7

3.1

estimate

0.0

1.23

315

3394

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3625

34839

1.30

7.61

13.5

10.1

umol/l

72.2

70.0

2.91

3625

34823

(3044889) 12 lead EKG panel

2036

18505

1.20

7.38

3.1

2.7

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

399

3037

1.35

6.97

11.2

6.0

mmol/l

1.1

1.30

382

2851

(3020779) Urea [Moles/volume] in Serum or Plasma

265

1888

1.43

6.89

14.4

7.9

mmol/l

8.4

7.3

2.34

259

1815

(3048689) Calprotectin [Mass/mass] in Stool

679

5565

1.26

6.82

2.5

2.7

ug/g

103.5

111.3

0.31

547

4358

(3029937) Albumin [Presence] in Urine by Test strip

1048

9007

1.22

6.78

3.9

3.3

estimate

0.0

0.11

325

3433

(3028026) IgM [Mass/volume] in Serum or Plasma

261

1864

1.43

6.70

1.9

1.7

g/l

1.3

0.50

247

1733

(3037522) Nuclear Ab [Titer] in Serum

586

4741

1.27

6.54

1.4

titre

488.5

533.6

0.22

104

886

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3090

29320

1.21

6.42

3.3

3.2

mmol/l

5.6

0.41

2934

27355

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1419

12602

1.19

6.39

2.6

2.2

nmol/l

71.8

71.1

0.42

1345

11730

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

334

2510

1.36

6.35

4.4

4.1

u/l

222.1

234.9

1.26

317

2380

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1475

13161

1.19

6.27

3.6

3.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

554

1.75

6.25

1.6

1.5

—

(3003338) MCHC [Mass/volume]

3336

31923

1.22

6.19

16.0

12.1

g/l

334.1

333.7

1.89

3310

31634

(3009261) Glucose [Presence] in Urine by Test strip

1851

16852

1.18

6.15

3.7

3.1

estimate

0.0

0.34

324

3410

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.30

6.13

6.5

2.8

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.30

6.13

6.5

2.8

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2867

27062

1.19

6.13

4.1

3.9

pmol/l

14.4

0.02

2659

24918

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

970

8361

1.21

5.99

2.8

2.7

ng/l

36.7

40.2

0.12

489

3808

(3021601) Nitrite [Presence] in Urine by Test strip

1836

16733

1.17

5.95

4.9

4.3

estimate

0.0

0.80

332

3522

(44790049)

324

1.96

5.91

2.0

1.5

—

(44790047)

324

1.96

5.91

2.0

1.5

—

(44806118)

324

1.96

5.91

2.0

1.5

—

(44790048)

324

1.96

5.91

2.0

1.5

—

(3012544) pH of Venous blood

284

2114

1.37

5.75

6.2

4.5

—

7.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

735

6195

1.23

5.66

2.8

2.3

umol/l

1522.5

3378.9

1.28

668

5546

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

483

3885

1.27

5.64

2.6

2.5

mmol/l

2.4

0.28

437

3393

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

638

5308

1.24

5.56

1.3

1.2

u/ml

8.9

0.00

249

2185

(3022217) INR in Platelet poor plasma by Coagulation assay

280

2095

1.36

5.50

17.0

13.6

inr

1.2

1.1

0.11

344

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

584

1.68

5.47

2.1

1.6

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

179

1250

1.45

5.25

3.1

2.5

e6/l

0.2

0.07

172

1202

(3023520) Reticulocytes [#/volume] in Blood

214

1544

1.41

5.25

2.6

2.8

e9/l

66.5

71.6

1.40

156

1132

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

816

7003

1.21

5.21

2.0

1.9

mg/l

1.2

1.0

0.92

582

4955

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

132

868

1.54

5.20

5.9

5.8

mg/l

1.5

1.2

2.97

127

820

(3017704) Immunofixation for Urine

3.01

5.09

1.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

328

1.87

5.07

3.6

2.9

1.3

1.4

0.12

267

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

187

1326

1.43

5.07

1.1

u/ml

4.8

4.3

0.08

200

(40758558) Short blood count panel - Blood

879

7617

1.19

5.04

6.9

6.4

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

4.45

5.03

11.8

5.0

mmol/l

5.0

6.4

0.89

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

144

973

1.50

5.01

1.9

1.8

—

(3027945) Reticulocytes/100 erythrocytes in Blood

297

2276

1.33

5.00

2.8

3.0

1.7

0.06

264

2035

(3002385) Erythrocyte distribution width [Ratio]

3170

30366

1.18

4.96

15.8

12.0

13.3

0.41

3105

29737

(3021960) Folate [Moles/volume] in Serum or Plasma

637

5361

1.22

4.95

1.5

1.4

nmol/l

20.3

20.1

0.10

568

4753

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

413

1.76

4.87

2.0

1.5

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

141

956

1.49

4.83

1.6

1.7

mmol/l

7.7

7.4

0.97

574

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2724

25817

1.16

4.77

4.3

4.0

mmol/mol

37.6

37.2

0.67

2615

24436

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

156

1083

1.46

4.76

2.0

1.9

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

244

1.98

4.73

2.1

2.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1966

18218

1.15

4.70

3.2

2.9

ug/l

79.6

72.8

1.00

1885

17179

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

539

6420

0.82

4.60

1.5

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3239

31141

1.18

4.59

4.9

4.5

mu/l

1.7

2.0

1.46

3113

29404

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

213

2.03

4.56

3.0

1.7

106.3

121.3

1.07

203

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

177

1271

1.41

4.51

2.3

2.0

u/l

40.0

38.8

0.39

166

1187

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

592

1.60

4.51

2.1

1.6

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

270

2080

1.32

4.41

6.3

4.4

kpa

5.9

0.13

259

2013

(3000494) Fungus identified in Specimen by Culture

410

3339

1.25

4.33

1.6

1.5

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

157

1113

1.43

4.31

3.2

2.9

g/l

3.5

0.11

147

1051

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

513

1.63

4.31

2.9

2.7

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

503

4191

1.23

4.31

2.9

ng/l

1317.4

828.9

1.53

425

3329

(40768446) Kidney Pathology biopsy report

139

2.24

4.24

2.1

1.6

—

(3000991) Gas panel - Venous blood

250

1917

1.32

4.23

10.7

8.6

—

(3011412) CD3 cells [#/volume] in Blood

335

1.77

4.18

2.2

2.7

e9/l

1.4

1.2

0.51

182

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

660

5663

1.20

4.18

1.3

iu/ml

17.4

24.0

2.07

205

1589

(3037756) Immunofixation for Serum or Plasma

256

1.89

4.15

1.8

1.5

—

(3002032) Base excess in Venous blood by calculation

266

2067

1.31

4.10

6.3

4.5

mmol/l

1.6

1.8

0.16

202

1654

(40761511) CBC panel - Blood by Automated count

3740

36505

1.23

4.10

12.2

9.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

335

2683

1.27

4.09

1.3

u/ml

210.3

241.0

0.35

305

2482

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

265

1.86

4.07

1.9

2.2

12.0

11.1

0.16

152

(3052592) Norovirus Ag [Presence] in Stool

3.52

4.04

1.3

1.4

—

(3045424) Erythrocytes [Presence] in Urine

515

1.60

4.02

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.94

4.00

1.6

1.7

—

(3009508) Creatinine [Moles/volume] in Urine

872

7691

1.17

3.97

4.0

3.4

mmol/l

8.0

8.4

1.58

769

6721

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

115

782

1.48

3.95

2.2

2.1

mg/l

11.7

9.9

1.59

109

742

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

107

717

1.51

3.95

2.9

2.3

ug/l

584.3

300.4

0.41

102

643

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1110

9983

1.15

3.89

1.4

1.3

u/ml

1.8

1.6

0.16

280

2734

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

271

1.82

3.82

2.2

2.8

e6/l

557.7

534.0

0.15

224

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

165

1210

1.38

3.77

1.4

1.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

508

1.59

3.77

4.3

4.1

u/ml

0.3

0.4

1.79

257

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.92

3.73

1.8

1.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

348

1.71

3.71

2.0

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

187

1404

1.35

3.69

1.3

u/ml

1.3

1.1

0.07

108

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

173

1288

1.36

3.62

6.9

4.8

mmol/l

24.0

24.1

0.15

154

1174

(3029634) Reagin Ab [Titer] in Serum by VDRL

114

790

1.46

3.60

2.2

1.8

titre

4.4

4.9

—

(1761868) Lipid panel - Serum or Plasma

1144

12571

0.88

3.54

2.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

131

2.15

3.51

2.0

1.8

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

542

1.54

3.49

1.7

g/l

0.7

0.12

410

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

243

1.82

3.47

1.9

1.7

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

608

1.51

3.45

1.1

—

(3028433) Virus identified in Specimen by Culture

106

2.27

3.45

1.5

1.2

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

384

3191

1.22

3.40

2.1

2.0

nmol/l

390.4

386.1

0.15

364

2935

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

267

1.77

3.39

2.2

2.8

e9/l

0.2

0.31

225

(3007164) IgA [Mass/volume] in Serum or Plasma

945

8477

1.15

3.39

1.5

1.4

g/l

2.0

2.1

0.64

622

5397

(3023323) Follitropin [Units/volume] in Serum or Plasma

325

2655

1.24

3.38

1.4

iu/l

17.2

17.6

0.08

281

2230

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

145

1062

1.38

3.38

1.7

1.9

g/l

0.2

0.41

134

1012

(3020682) Albumin/Creatinine [Ratio] in Urine

637

5549

1.17

3.37

4.9

4.3

mg/mmol

10.8

12.6

0.44

437

3768

(4024509)

246

1.80

3.35

1.8

1.4

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

3.25

3.34

1.2

1.1

—

224.8

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

254

1.78

3.32

1.1

1.3

titre

80.0

233.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

123

880

1.41

3.30

1.3

1.4

titre

73.8

84.6

0.30

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

204

1.87

3.29

1.1

—

(3026782) Osmolality of Urine

624

5438

1.17

3.29

3.1

2.5

mosm/kgh2o

471.9

560.7

0.69

545

4639

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

151

1119

1.36

3.28

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

198

1.88

3.24

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

512

1.53

3.23

1.4

1.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

651

1.47

3.21

1.9

2.0

ug/l

2.9

2.0

0.32

576

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

287

1.72

3.20

1.8

1.6

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

127

921

1.39

3.16

1.9

2.0

g/l

1.3

0.08

112

812

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

281

1.72

3.15

2.1

1.4

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

342

1.65

3.14

1.4

g/l

2.9

0.06

235

(3024139) IgG subclass 3 [Mass/volume] in Serum

342

1.65

3.14

1.4

g/l

0.4

0.50

233

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1694

15830

1.12

3.10

4.4

3.9

—

(3012516) Albumin [Mass/volume] in Urine

609

5326

1.17

3.07

4.3

3.5

mg/l

1144.2

381.5

1.68

428

3608

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

374

3134

1.21

3.07

4.1

2.8

umol/l

6.0

6.6

0.44

323

2648

(3000330) Specific gravity of Urine by Test strip

1232

0.68

3.06

2.3

2.7

—

(21494815) CD4 cells/100 lymphocytes in Specimen

299

1.68

3.05

1.9

2.5

39.7

46.5

—

(3025315) Body weight

5.01

3.05

2.5

2.4

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

174

1.90

3.04

2.4

2.8

42.7

43.9

0.14

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

315

1.66

3.02

1.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3618

35365

1.17

3.02

9.9

7.9

u/l

26.6

26.2

0.56

3534

34264

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

578

1.48

3.01

1.3

1.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

146

1093

1.35

3.00

1.7

1.9

g/l

1.2

0.68

136

1043

(4062490)

347

1.62

2.99

1.5

1.4

—

(40757373) Influenza virus identified in Isolate

3.01

2.97

1.8

1.9

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

325

1.64

2.95

1.4

1.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

269

2190

1.24

2.92

3.2

2.6

g/l

0.2

0.79

253

2039

(3000850) Epithelial cells [#/volume] in Urine

659

5821

1.16

2.92

3.0

2.4

e6/l

6.9

8.3

1.24

577

5063

(3027135) IgG subclass 1 [Mass/volume] in Serum

342

1.62

2.90

1.4

g/l

6.3

6.4

0.10

237

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

235

1887

1.26

2.89

2.7

2.2

ml/min/173m2

76.1

80.0

0.65

678

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

154

1170

1.33

2.88

2.7

2.6

95.0

94.3

0.14

148

1072

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

4.10

2.88

2.9

3.9

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

943

8548

1.13

2.85

1.5

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

157

1.92

2.84

2.7

1.7

113.1

135.5

1.06

148

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

298

1.65

2.83

2.1

1.5

—

(40768804) Tissue Pathology biopsy report

1282

11846

1.12

2.80

1.9

—

(3017181) Myelocytes/100 leukocytes in Blood

288

2374

1.23

2.80

4.2

4.3

0.8

0.10

559

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3143

30473

1.13

2.80

3.4

3.2

mmol/l

4.7

0.04

3025

28983

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

3.92

2.77

3.0

3.8

—

(3007461) Platelets [#/volume] in Blood

3986

39352

1.27

2.77

18.6

14.6

e9/l

261.0

261.3

0.12

3921

38456

(3019309) Folate [Moles/volume] in Red Blood Cells

434

3727

1.18

2.75

1.6

nmol/l

1161.5

1169.3

0.06

347

2877

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

761

6820

1.14

2.74

1.7

1.6

mmol/l

1.4

1.04

688

5995

(3023419) Bacteria identified in Sputum by Culture

219

1.74

2.68

3.7

4.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.39

2.63

2.8

2.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

448

1.50

2.62

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

207

1.75

2.57

1.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

271

3257

0.82

2.57

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

270

3244

0.82

2.55

1.4

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

7.15

2.55

1.6

2.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

215

2644

0.80

2.54

1.5

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3156

30662

1.12

2.53

3.7

3.4

mmol/l

2.8

0.05

3020

28938

(3023511) Choriogonadotropin [Units/volume] in Urine

291

2429

1.21

2.53

1.4

—

(3024932) HLA-DR beta [Type]

108

2.04

2.51

1.0

1.1

—

(3024471) HLA-A [Type]

108

2.04

2.51

1.0

—

(3022145) Colonoscopy Study observation

347

2951

1.19

2.48

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

273

3264

0.82

2.46

1.4

1.5

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

621

1.41

2.45

1.3

—

(3035941) MCH [Entitic mass]

3987

39402

1.25

2.44

18.5

14.4

30.0

29.9

1.93

3948

38952

(3010813) Leukocytes [#/volume] in Blood

3989

39424

1.25

2.44

18.6

14.6

e9/l

6.8

0.66

3919

38459

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.24

2.43

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

273

3260

0.83

2.43

1.4

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

152

1.85

2.42

1.1

1.2

g/l

0.3

1.19

121

(40761536) Microorganisms panel - Urine sediment

271

3234

0.83

2.40

3.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

117

880

1.34

2.40

4.1

3.5

mmol/l

25.0

0.00

111

849

(3000492) Spirometry study

395

3409

1.18

2.38

1.4

1.3

—

(3024731) MCV [Entitic volume]

3986

39400

1.24

2.37

18.5

14.5

89.6

89.4

1.10

3947

38949

(3026361) Erythrocytes [#/volume] in Blood

3987

39411

1.24

2.37

18.6

14.5

e12/l

4.6

1.70

3919

38464

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

329

1.56

2.37

2.3

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

243

1.65

2.37

2.0

3.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3246

31624

1.12

2.36

4.0

3.9

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

111

1.99

2.35

1.2

1.1

—

(3037121) Protein [Mass/volume] in Urine

128

981

1.31

2.32

3.1

3.5

g/l

0.3

0.4

0.78

467

(3002179) Metamyelocytes/100 leukocytes in Blood

263

2195

1.21

2.31

4.0

4.1

0.6

0.05

419

(3017143) Hepatitis C virus Ab [Presence] in Serum

760

6885

1.13

2.30

1.9

1.6

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

2.86

2.30

1.4

1.7

g/l

9.0

12.7

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

193

1.72

2.26

2.7

52.2

54.0

0.15

131

(3025159) Blasts/100 leukocytes in Blood

261

2183

1.21

2.25

4.4

0.1

0.3

0.41

443

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

556

1.41

2.24

2.8

1.9

g/l

3.0

3.1

0.33

451

(3051651) Icteric interference index of Serum or Plasma

164

1.77

2.22

7.6

3.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.34

2.21

1.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

408

1.48

2.21

1.6

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

360

1.51

2.19

1.5

1.4

—

(3005570) Glucose [Moles/volume] in Urine

304

1.55

2.18

2.0

2.3

—

1.0

—

(3000475) Leukocytes [#/volume] in Synovial fluid

484

1.43

2.18

1.7

e6/l

16271.4

12836.4

0.18

359

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

688

1.36

2.16

1.6

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

198

0.40

2.15

3.3

2.2

—

(3051611) Lipemic interference index of Serum or Plasma

219

1.65

2.15

6.7

3.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

362

1.50

2.14

1.5

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

362

1.50

2.14

1.5

1.4

—

(3000963) Hemoglobin [Mass/volume] in Blood

3986

39432

1.23

2.12

18.7

14.6

g/l

135.8

136.1

0.86

3951

38982

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3109

30274

1.10

2.12

3.4

3.2

mmol/l

1.4

1.5

0.40

2988

28715

(3005988) Vibrio sp identified in Specimen by Organism specific culture

363

1.49

2.12

1.5

1.4

—

(3003694) ABO and Rh group [Type] in Blood

1242

13266

0.91

2.11

1.7

1.8

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

572

0.63

2.11

1.1

1.7

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

267

1.58

2.11

1.5

1.3

u/ml

0.6

0.3

0.41

(3036489) Thrombin time

162

1299

1.26

2.10

2.7

2.4

21.4

21.0

0.79

141

1090

(3021440) Promyelocytes/100 leukocytes in Blood

269

2276

1.19

2.07

4.3

4.4

0.1

0.60

518

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

681

6171

1.12

2.06

2.0

1.9

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

117

1.88

2.05

1.4

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

139

1.80

2.04

1.3

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

499

1.41

2.04

1.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

136

1072

1.28

2.04

1.8

2.1

—

(3044640) Blood type and Crossmatch panel - Blood

1057

9815

1.10

2.03

2.5

2.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

311

1.52

2.00

1.4

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.00

1.3

1.1

—

(3011648) Oxygen content in Venous blood

193

1.66

1.99

4.0

4.3

10.4

11.6

1.06

193

(3005033) Fetal Nuchal fold Thickness US

215

2567

0.83

1.96

1.4

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

370

1.47

1.95

1.5

1.4

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

105

1.91

1.95

7.8

5.9

mg/l

57.5

75.8

0.82

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

563

5062

1.13

1.94

1.5

1.6

pmol/l

94280509.7

34269187.8

0.99

507

4383

(3047352) Trisomy 18 risk [Likelihood] in Fetus

216

2575

0.83

1.94

1.4

1.5

—

(3049242) von Willebrand panel - Platelet poor plasma

4.55

1.94

1.6

1.7

—

(3022689) Creatine [Moles/volume] in Urine

2.19

1.94

1.1

1.8

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

667

1.34

1.93

1.2

1.3

ug/g

285.8

316.2

0.65

331

(3028717) Thiamine [Mass/volume] in Blood

2.97

1.93

1.3

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.97

1.93

1.0

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.73

1.93

2.4

2.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.73

1.93

1.9

1.6

ng/l

113.0

104.9

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

652

1.34

1.90

1.2

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

373

4243

0.87

1.89

1.4

1.5

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

524

1.38

1.89

1.4

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

365

1.46

1.88

1.5

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

525

1.38

1.87

1.4

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

115

1.83

1.82

1.4

1.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

579

1.35

1.82

2.8

1.8

g/l

7.2

7.4

0.20

462

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

579

1.35

1.82

2.8

1.8

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

579

1.35

1.82

2.8

1.8

g/l

3.9

3.8

0.25

437

(3004119) Hemoglobin [Mass/volume] in Venous blood

150

1215

1.24

1.82

5.6

3.5

g/l

126.2

133.1

3.46

140

1191

(3034426) Prothrombin time (PT)

130

1.77

1.81

1.3

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

246

1.55

1.81

2.4

2.1

—

(3044941) Cell count panel - Synovial fluid

328

1.47

1.78

1.5

—

(4034850)

110

861

1.29

1.78

12.2

7.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

395

1.42

1.77

1.1

1.4

—

(3033658) Prothrombin time (PT) actual/Normal

748

6878

1.11

1.74

5.3

3.7

95.0

94.9

0.04

729

6675

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

116

917

1.27

1.74

2.0

1.4

u/ml

113.7

107.8

0.32

166

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

166

1367

1.22

1.74

2.2

2.3

ug/l

7.6

6.6

0.29

153

1201

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

308

3527

0.86

1.73

1.4

1.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2975

29011

1.09

1.72

3.1

2.9

mmol/l

1.2

0.96

2857

27514

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

123

981

1.26

1.72

11.4

10.4

mmol/l

24.0

24.2

0.34

117

940

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.85

1.71

1.0

1.3

—

(3013336) Amino acids [Identifier] in Serum or Plasma

3.85

1.71

1.2

3.6

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

517

1.36

1.71

5.4

5.6

umol/l

426.5

369.2

2.76

448

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

122

974

1.26

1.70

2.0

1.4

u/ml

15.9

23.6

—

(3023183) Ammonium ion [Moles/volume] in Plasma

475

1.37

1.69

5.2

3.0

umol/l

35.1

32.7

0.33

418

(3014111) Lactate [Moles/volume] in Serum or Plasma

225

1914

1.19

1.68

9.1

7.1

mmol/l

1.3

0.16

208

1832

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

275

2379

1.17

1.68

3.5

3.3

pmol/l

4.6

4.7

0.28

251

2142

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3037

29657

1.09

1.66

10.7

8.2

ml/min/173m2

96.9

97.4

0.59

2338

23406

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

284

1.48

1.66

1.3

1.2

—

(3036180) Methadone [Presence] in Urine

3.16

1.66

1.8

2.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

285

1.48

1.64

1.3

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

277

1.48

1.63

5.7

3.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

213

1.55

1.62

1.7

2.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

369

1.41

1.61

5.0

3.1

mg/l

50.7

29.9

1.04

297

(3034860) Kappa light chains.free [Mass/volume] in Serum

369

1.41

1.61

5.1

3.2

mg/l

52.9

62.5

0.18

297

(3014576) Chloride [Moles/volume] in Serum or Plasma

293

2557

1.16

1.61

8.7

7.0

mmol/l

104.5

104.8

0.54

286

2502

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

191

1609

1.20

1.61

1.6

1.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

164

1363

1.21

1.59

1.7

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

362

1.41

1.59

4.5

3.1

ratio

9.0

1.6

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

622

0.70

1.53

3.5

2.8

mg/l

42.2

23.4

1.36

378

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

384

3430

1.13

1.51

1.2

iu/ml

118.9

147.6

0.77

152

1285

(3000060) B lymphocytes [#/volume] in Blood

138

1.67

1.51

1.7

2.2

e6/l

197.7

220.5

0.11

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

263

3012

0.86

1.51

1.2

1.3

—

(3045142) Bone marrow Pathology biopsy report

193

1.56

1.51

1.2

1.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1274

12072

1.08

1.50

1.9

1.8

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

154

1.63

1.49

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

119

967

1.24

1.46

2.1

1.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

690

1.28

1.46

2.6

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

412

1.36

1.44

1.3

u/ml

17.7

44.5

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.13

1.44

1.2

1.4

nmol/l

367.1

483.8

—

(3020630) Protein [Mass/volume] in Serum or Plasma

165

1389

1.20

1.43

3.2

2.2

g/l

66.6

67.6

1.25

158

1297

(3052851) Hemolysis interference index of Serum or Plasma

764

1.26

1.42

4.7

2.7

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

268

2349

1.15

1.42

1.4

1.3

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

668

1.28

1.39

4.7

3.8

52.1

56.1

2.07

668

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

181

1.55

1.39

1.8

2.5

mg/l

10.1

10.0

0.00

154

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

415

1.35

1.39

1.7

1.6

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

262

0.57

1.37

1.3

1.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

670

1.27

1.37

2.0

1.6

titre

784.0

3347.4

—

(3010503) CD19 cells [#/volume] in Blood

182

1.54

1.37

2.4

3.1

e9/l

0.2

0.06

177

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.94

1.36

1.2

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

654

1.27

1.34

3.7

3.6

e9/l

3.5

4.0

1.72

654

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

199

1.51

1.34

1.0

1.1

u/ml

22.3

12.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

223

2557

0.86

1.33

1.5

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.04

1.32

1.1

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

136

1.62

1.32

1.9

2.0

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

137

1144

1.20

1.32

1.4

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

131

1090

1.21

1.31

1.4

1.3

u/ml

249.8

232.9

0.21

660

(1002224) Polysomnography panel

171

1458

1.18

1.31

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.10

1.30

1.2

1.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1010

10683

0.93

1.30

1.8

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

439

1.33

1.27

3.9

2.9

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

300

2673

1.13

1.27

2.5

2.4

u/l

33.3

52.8

0.55

260

2276

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.79

1.27

1.0

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

379

1.35

1.26

1.7

1.6

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1279

12193

1.07

1.26

2.4

—

(3018095) Leukocytes [#/volume] in Urine

1128

10707

1.07

1.25

4.3

3.3

e6/l

63.9

68.0

0.09

781

6921

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

173

1483

1.17

1.25

3.4

4.1

ug/l

4.1

46.9

1.10

128

1114

(3014051) Protein [Presence] in Urine by Test strip

733

0.76

1.24

1.8

1.9

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

281

2502

1.13

1.21

1.4

1.3

miu/ml

206.4

229.5

0.53

132

1254

(3024928) Oxygen saturation in Venous blood

478

1.30

1.21

7.2

3.8

—

(3038515) Glucose [Moles/volume] in Venous blood

349

0.66

1.21

2.2

2.9

mmol/l

6.8

7.1

0.16

341

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.72

1.21

1.8

1.6

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

611

1.27

1.21

1.2

1.1

—

(3049717) Cytology report of Urine Cyto stain

505

1.29

1.20

2.6

2.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

168

0.53

1.18

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

341

1.35

1.17

2.2

1.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

468

4296

1.10

1.17

1.6

1.5

—

(3012501) Base excess in Blood by calculation

578

0.74

1.16

3.8

3.4

mmol/l

1.8

2.1

0.25

329

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

818

7695

1.08

1.16

2.2

2.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

624

1.25

1.15

1.3

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

308

1.37

1.15

1.0

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

868

0.79

1.14

1.4

1.5

—

(3024354) Oxygen [Partial pressure] in Venous blood

200

1750

1.15

1.13

5.4

4.0

kpa

5.0

4.8

0.87

192

1688

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

501

1.28

1.13

3.1

2.0

g/l

0.7

0.00

458

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

387

1.32

1.13

2.4

1.7

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

546

1.27

1.12

5.8

2.8

mmol/l

23.2

24.2

1.71

493

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.34

1.12

1.0

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

267

1.39

1.12

2.2

2.9

e6/l

1043.1

847.3

0.71

111

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

520

1.27

1.11

1.4

—

(3017732) Neutrophils [#/volume] in Blood

256

2281

1.13

1.11

2.9

2.2

e9/l

4.2

0.05

216

1905

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

192

1.46

1.11

1.7

1.6

nmol/l

1.5

2.8

0.64

153

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.78

1.10

1.9

2.1

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

2.26

1.10

1.1

1.0

—

45.3

—

(4010399)

205

1802

1.14

1.10

1.5

1.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

124

1048

1.19

1.09

2.7

1.9

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

638

1.24

1.09

1.3

u/ml

1.2

3.0

—

(40768797) Stomach Pathology biopsy report

381

3477

1.11

1.09

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

112

1.61

1.08

1.7

2.2

—

(3002582) Erythrocytes [#/volume] in Urine

894

8461

1.07

1.08

3.7

2.9

e6/l

33.4

85.4

1.87

723

6318

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

219

1.42

1.06

1.2

u/l

57.5

60.3

0.13

147

(3045683) HLA typing for celiac disease panel - Blood or Tissue

326

0.67

1.06

1.0

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

170

1479

1.16

1.06

5.1

3.5

kpa

5.1

0.25

164

1396

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

105

1.62

1.06

1.2

1.9

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

105

1.62

1.06

1.2

1.9

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.12

1.05

3.0

4.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

203

1.43

1.05

1.3

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.64

1.03

1.5

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.64

1.03

1.5

1.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

536

1.25

1.02

2.2

1.9

g/l

9.8

10.6

0.74

471

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

826

1.20

1.02

1.4

1.3

u/ml

1.6

4.4

2.35

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

171

1.46

1.02

1.2

1.1

95.4

94.7

0.05

(3042631) Mycobacterium sp identified in Specimen

196

1.43

1.02

2.3

3.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

362

3310

1.10

1.01

3.4

3.3

21.9

21.3

0.24

122

1180

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

100

838

1.20

0.99

1.4

1.3

u/ml

28.3

11.8

0.44

123

(3006922) Hepatitis E virus Ab [Presence] in Serum

257

1.36

0.98

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

2.18

0.98

1.4

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

388

1.29

0.98

1.4

1.9

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1048

10006

1.06

0.97

2.9

2.7

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

685

1.22

0.96

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.80

0.96

1.1

1.2

—

(4038314)

1.85

0.96

1.3

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

108

915

1.19

0.96

1.4

1.3

u/ml

26.4

29.3

—

(3010421) pH of Blood

669

0.79

0.95

3.5

3.3

7.4

0.60

568

(3050129) First trimester maternal screen panel - Serum or Plasma

395

4280

0.91

0.95

1.4

1.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

141

1.49

0.94

2.1

nmol/l

1.1

1.5

0.47

116

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.89

0.94

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

217

1.39

0.93

1.2

1.1

—

(3019225) pH of Specimen

245

2212

1.11

0.89

3.7

3.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

162

1426

1.14

0.89

5.1

3.5

mmol/l

1.1

1.2

0.08

105

1003

(40768441) Liver Pathology biopsy report

202

1.39

0.89

2.8

1.5

—

(3032773) Endomysium IgG Ab [Titer] in Serum

416

0.74

0.88

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.91

0.88

1.9

1.5

—

(3009343) pH of Capillary blood

166

1466

1.14

0.88

5.1

3.5

7.4

0.15

187

(4035726)

207

1855

1.12

0.87

1.6

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

232

2093

1.11

0.87

1.4

1.5

u/l

8.7

8.1

0.11

189

1738

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.82

0.85

1.1

2.2

—

(3021589) Normoblasts [#/volume] in Blood

1518

14700

1.05

0.84

9.2

8.1

e9/l

0.0

0.68

1235

12113

(4268621)

451

1.24

0.84

2.3

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

162

1.42

0.84

1.2

101.2

93.5

0.58

(40760892) CBC W Ordered Manual Differential panel - Blood

876

8360

1.06

0.83

4.4

4.0

—

(3045414) Leukocytes [Presence] in Urine

161

1425

1.14

0.83

1.6

1.7

—

(3008898) HLA-B27 [Presence]

206

1853

1.12

0.82

1.1

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

1.74

0.82

1.0

u/ml

0.0

0.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

376

0.74

0.82

1.0

1.1

u/ml

0.4

2.6

1.45

121

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

181

1618

1.12

0.81

2.4

2.3

u/ml

36.3

35.3

0.04

175

1566

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

459

4294

1.08

0.80

3.1

2.6

e6/l

4.0

0.02

275

2223

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

582

1.21

0.79

3.5

3.8

u/ml

79.0

2512.7

0.78

490

(4211845)

181

1.38

0.79

1.5

2.3

—

(4306422)

647

1.19

0.79

1.1

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

190

1.37

0.78

1.4

e6/l

41913.6

67742.5

0.24

132

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.67

0.78

5.5

6.8

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.67

0.78

2.1

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

496

0.78

3.1

2.3

17.5

17.2

0.15

239

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

100

0.50

0.77

1.0

1.1

—

(3008037) Lactate [Moles/volume] in Venous blood

383

0.76

0.77

2.0

2.8

mmol/l

1.4

0.06

370

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

115

1.48

0.76

2.7

3.6

—

(1761482) Bacteria [#/volume] in Urine by Culture

494

0.79

0.76

2.1

3.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

382

0.76

1.0

1.1

u/ml

3.0

2.7

0.05

101

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

468

4982

0.93

0.75

2.0

2.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

118

1032

1.15

0.75

1.2

1.1

—

(3033799) Differential panel - Peritoneal fluid

1.84

0.73

2.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.64

0.73

4.6

6.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

452

4244

1.07

0.73

3.7

ug/l

2.2

1.8

0.27

415

3861

(3002523) Influenza virus A Ag [Presence] in Specimen

915

0.85

0.72

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.61

0.72

1.0

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

183

0.65

0.72

2.8

2.0

nmol/l

153.0

150.5

0.03

157

(3044007) Cell count panel - Peritoneal fluid

1.75

0.71

1.4

2.2

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

151

1.39

0.71

3.3

2.4

ug/l

1.2

1.1

0.10

137

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

238

1.30

0.70

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

119

1048

1.14

0.70

1.2

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.71

0.70

1.0

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

135

1.41

0.69

1.1

96.7

92.7

0.34

135

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

135

1.41

0.69

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

285

0.74

0.68

1.9

1.6

—

(3013637) Mi-2 Ab [Presence] in Serum

1.64

0.68

1.2

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.64

0.68

1.2

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.64

0.68

1.2

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.64

0.68

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.53

0.68

1.7

1.3

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.53

0.68

1.6

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

118

1041

1.14

0.68

1.2

1.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

1.79

0.66

1.8

2.5

pmol/l

33.7

59.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

249

2699

0.92

0.66

1.4

1.6

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

484

4575

1.07

0.65

2.1

2.4

u/l

7071.8

6771.0

0.06

177

1859

(3042111) Morphology [Interpretation] in Bone marrow Narrative

259

1.28

0.65

1.8

2.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1151

11142

1.05

0.64

2.2

2.3

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

224

1.30

0.64

2.7

3.0

au/ml

44.8

137.6

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

261

2820

0.92

0.64

6.1

4.7

—

(4146454)

166

0.66

0.64

3.4

2.9

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

242

1.28

0.64

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.48

0.64

1.2

2.0

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

115

1019

1.13

0.63

2.3

2.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

913

0.86

0.63

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

235

0.72

0.63

1.2

1.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

190

1.32

0.62

1.2

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

190

1.32

0.62

1.2

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

190

1.32

0.62

1.2

1.6

—

(3045716) Anion gap in Serum or Plasma

104

1.44

0.62

3.4

2.3

mmol/l

8.2

9.3

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

1.60

0.61

2.8

3.8

—

9.6

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.60

0.61

1.1

1.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

647

1.16

0.61

1.2

1.3

u/ml

3.1

4.1

0.64

299

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

741

1.15

0.60

1.4

1.2

u/ml

42.1

43.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

367

0.79

0.60

1.6

1.5

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

299

1.24

0.59

1.2

1.4

75.4

73.6

0.49

282

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

290

1.24

0.59

1.2

1.4

mu/l

513.9

465.5

0.25

273

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

290

1.24

0.59

2.4

1.7

—

(3025941) Bacteria identified in Stool by Culture

244

2261

1.08

0.59

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

345

1.22

0.58

3.8

4.1

u/ml

79.2

81.4

0.02

108

(3024891) Influenza virus A+B Ag [Presence] in Specimen

122

1093

1.12

0.58

1.2

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.72

0.57

1.2

1.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.67

0.56

1.2

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

115

1.39

0.56

1.8

1.7

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

319

2993

1.07

0.56

1.5

1.6

mu/l

311.1

308.1

0.05

302

2682

(3014133) Dog dander IgE Ab [Units/volume] in Serum

112

1001

1.12

0.56

1.1

u/ml

8.5

4.5

0.32

426

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.46

0.56

1.8

1.1

—

(3047189) Immunofixation for 24 hour Urine

1.46

0.56

1.4

1.7

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

728

1.14

0.55

1.6

mmol/l

6.7

6.6

0.05

505

(3028679) Herpes simplex virus Ab [Presence] in Serum

320

1.22

0.55

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.62

0.55

1.2

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.45

0.55

1.0

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

168

1.31

0.55

6.8

7.0

—

(3025130) Human papilloma virus identified in Specimen

748

1.14

0.54

2.0

1.8

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

103

918

1.13

0.54

1.1

u/ml

10.2

7.0

0.28

421

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

116

1.38

0.54

1.3

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

116

1.38

0.54

1.3

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

116

1.38

0.54

1.3

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

116

1.38

0.54

1.3

1.8

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

1.42

0.54

1.0

u/ml

0.0

0.1

—

(3006462) Nitrate [Presence] in Urine

160

1.31

0.53

1.6

2.3

—

(40768800) Prostate Pathology biopsy report

193

0.72

0.53

1.4

1.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

137

1244

1.10

0.53

1.6

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

134

1.34

0.53

1.9

1.5

u/l

6.5

4.7

0.24

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.43

0.53

1.2

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.43

0.53

1.2

2.0

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

602

5772

1.05

0.52

1.9

1.7

1.4

0.24

560

5226

(3020650) Glucose [Presence] in Urine

117

1.37

0.52

1.7

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

291

2733

1.07

0.51

1.1

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

105

942

1.12

0.51

6.0

3.2

0.7

0.10

915

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

152

1391

1.10

0.51

1.1

u/ml

2.5

1.8

0.38

612

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

206

1.26

0.50

1.5

1.7

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1010

0.89

0.50

1.6

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.41

0.50

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.41

0.50

1.1

—

(3012441) Differential panel - Pleural fluid

110

1.36

0.48

1.3

1.4

—

(3024263) Appearance of Synovial fluid

110

1.36

0.48

2.4

2.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.45

0.48

1.3

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

208

1.25

0.47

1.3

1.4

nmol/l

1.2

1.5

0.84

192

(4094501)

506

0.85

0.47

1.0

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

200

1.25

0.46

1.0

1.1

u/ml

100.2

8.8

0.45

120

(3000012) Reticulocyte production index

1.38

0.46

1.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

366

1.18

0.45

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

118

1292

0.91

0.44

1.8

1.5

—

(36304419) Bacteria [Presence] in Urine

802

7777

1.04

0.43

3.4

2.7

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.37

0.43

1.1

—

(3016038) Potassium [Moles/volume] in Urine

131

0.69

0.43

1.1

1.4

mmol/l

36.7

35.3

—

126

(3020491) Glucose [Moles/volume] in Blood

295

0.81

0.42

1.3

1.6

mmol/l

5.5

5.8

0.65

244

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

285

1.19

0.42

1.2

1.3

pmol/l

50.5

60.7

0.20

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

229

0.79

0.42

1.9

2.0

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

462

1.15

0.42

1.8

1.9

g/l

39.0

38.7

0.15

417

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2430

24002

1.03

0.42

3.3

2.8

u/l

41.9

34.6

2.14

2345

22943

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

149

1.28

0.41

10.7

7.0

u/ml

36.8

225.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.36

0.41

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.0

—

(3035880) pH of Pleural fluid

1.36

0.41

1.1

1.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.40

0.0

1.5

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.33

0.40

1.3

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

273

2880

0.94

0.40

3.1

32.9

32.0

0.79

218

2158

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

107

978

1.10

0.40

2.1

iu/l

4.3

4.0

0.13

387

(44806071)

1.31

0.39

1.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

664

1.12

0.39

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

0.39

0.0

1.4

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.1

—

0.2

—

(3043409) Potassium [Moles/volume] in Arterial blood

551

1.13

0.38

4.4

4.2

mmol/l

3.8

0.01

510

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

173

1849

0.93

0.38

1.5

1.6

mg/l

4.4

4.1

0.08

116

1212

(3015076) Soybean IgE Ab [Units/volume] in Serum

356

0.84

0.38

1.1

1.0

u/ml

0.5

2.0

—

(1616796) Gas panel - Central venous blood

568

0.88

0.37

3.9

3.1

—

(3022313) Gas panel - Capillary blood

115

1059

1.09

0.37

4.4

3.8

—

(3045788) Cell count panel - Pleural fluid

1.33

0.37

1.4

1.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

667

1.11

0.37

1.3

u/ml

2.9

3.9

0.28

238

(3010726) Horse dander IgE Ab [Units/volume] in Serum

129

1197

1.08

0.36

1.1

u/ml

1.8

2.7

0.50

338

(21494434) Karyotype in Bone marrow

157

0.76

0.35

1.1

1.2

—

(3020891) Body temperature

756

1.10

0.35

5.1

4.6

—

(3002256) Pathology report gross observation

334

3484

0.96

0.34

1.3

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

349

1.15

0.33

1.6

1.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

478

0.88

0.33

2.9

2.6

ug/min

74.7

117.1

0.62

312

(3030467) Casts [#/volume] in Urine by Automated count

791

7714

1.03

0.33

3.5

2.8

e6/l

0.4

0.3

0.35

620

5655

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.30

0.33

2.3

5.0

—

(3016018) Differential panel - Cerebral spinal fluid

403

0.87

0.33

1.8

1.6

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

323

1.15

0.31

1.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.72

0.30

3.9

1.4

—

(3020393) Adenovirus Ag [Presence] in Stool

1.32

0.30

1.1

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

193

1.19

0.30

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.27

0.30

1.0

1.1

—

(40768795) Lymph node Pathology biopsy report

231

1.17

0.29

1.4

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

109

0.73

0.29

1.8

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

323

0.87

0.28

1.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

103

1.26

0.28

1.2

1.4

—

1101.7

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.29

0.28

1.6

1.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

757

7402

1.03

0.28

2.4

2.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

233

1.16

0.27

1.1

1.3

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

168

1.19

0.27

1.3

1.2

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

1.21

0.26

1.3

1.0

ug/l

66.2

69.9

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

568

1.09

0.26

1.4

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

301

1.13

0.25

2.1

2.0

—

(3006270) Folate [Moles/volume] in Blood

207

1.16

0.25

1.0

1.1

nmol/l

385.9

409.0

0.27

196

(3020191) Ethanol [Moles/volume] in Serum or Plasma

368

1.12

0.25

1.6

1.5

promille

1.3

0.01

281

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

361

0.89

0.24

1.2

1.4

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

239

2298

1.04

0.24

2.3

au/ml

19.7

19.1

0.03

190

(3017509) Phencyclidine [Presence] in Urine

0.71

0.24

1.3

1.7

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

199

1.16

0.23

2.0

3.7

umol/l

78.1

199.8

4.15

108

(3021901) Oxygen saturation in Capillary blood

370

1.11

0.23

2.9

2.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

274

0.88

0.22

1.0

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.25

0.22

1.0

—

(3011288) Drugs identified in Urine by Screen method

265

2743

0.96

0.22

3.6

3.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

153

1.18

0.22

1.0

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

257

1.13

0.22

1.4

1.6

44.1

51.8

0.53

184

(44813793)

347

0.89

0.22

1.1

1.0

—

(3032057) Clostridioides difficile [Presence] in Stool

1.22

0.22

2.6

2.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.22

0.22

6.2

2.3

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

1.22

0.22

1.2

1.1

mmol/l

23.2

20.6

—

(3040151) Glucose [Moles/volume] in Capillary blood

294

0.88

0.21

4.8

7.0

mmol/l

7.3

6.6

0.34

235

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.19

0.21

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.21

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.21

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.21

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.21

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.21

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.21

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3006653) Thiamine [Moles/volume] in Blood

135

1.19

0.21

1.3

1.5

nmol/l

122.7

136.1

0.70

135

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.3

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

546

1.08

0.21

1.5

2.6

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

142

1355

1.05

0.21

2.3

2.4

umol/l

5.2

5.3

0.00

111

1005

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.16

0.21

1.0

1.3

—

(3007463) Buprenorphine [Presence] in Urine

1.16

0.21

13.4

4.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

195

1875

1.04

0.21

1.5

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

133

1267

1.05

0.21

1.4

1.3

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.21

0.0

1.5

—

(3023410) Appearance of Cerebral spinal fluid

408

0.91

0.20

2.0

1.9

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

268

1.12

0.20

3.1

1.7

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

117

1.20

0.20

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.00

0.20

0.0

1.1

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.20

0.0

1.8

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

131

1249

1.05

0.20

1.5

1.6

iu/ml

1.9

0.2

0.45

231

(37021550) Renin [Units/volume] in Plasma --upright

1.25

0.20

1.8

1.5

mu/l

58.6

199.8

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

319

3100

1.03

0.20

2.6

2.3

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

111

0.81

0.20

1.4

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1494

15099

0.98

0.20

2.2

2.1

—

(4027681)

365

0.90

0.19

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.22

0.19

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

155

1613

0.96

0.18

1.7

1.5

—

(21494755) Public health laboratory ask at order entry panel

540

5296

1.02

0.18

1.2

1.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.19

0.18

1.1

1.0

—

(3021788) Differential panel - Synovial fluid

383

0.91

0.17

1.6

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

263

2555

1.03

0.17

2.3

2.1

nmol/l

10.4

11.1

0.74

234

2296

(40761535) Cells panel - Urine sediment

209

2023

1.03

0.17

3.6

3.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

572

1.07

0.17

1.3

1.2

—

(3014271) Vancomycin [Susceptibility]

0.76

0.17

3.8

2.3

—

(3002619) Bacteria identified in Specimen by Culture

0.76

0.17

1.0

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.16

0.16

11.8

3.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

120

1.17

0.16

1.2

mmol/l

5.5

6.1

0.41

112

(3030313) Adrenal Ab [Titer] in Serum

1.13

0.16

1.1

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

308

0.91

0.16

3.3

3.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

723

7126

1.02

0.16

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

111

1.17

0.15

3.6

1.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

452

0.93

0.15

1.1

1.0

—

(3017569) Oxygen content in Arterial blood

1.14

0.15

2.8

2.7

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

849

1.05

0.15

1.3

1.4

u/l

14.3

15.9

0.31

743

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

554

0.94

0.15

4.8

2.7

nmol/l

0.9

0.8

0.08

474

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

840

1.05

0.14

1.5

1.4

mmol/l

3.4

3.6

1.32

788

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.80

0.14

1.4

ug/l

8.6

8.1

—

(3027944) Amphetamines [Presence] in Urine

396

3886

1.02

0.14

1.9

2.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

160

1.13

0.14

1.5

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

266

1.09

0.14

1.1

iu/ml

5.9

7.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

170

0.88

0.13

1.0

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

155

1502

1.03

0.13

1.6

1.7

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

623

0.95

0.13

1.1

iu/ml

67.6

2241.7

0.77

182

(3013512) EKG study

620

6115

1.02

0.13

2.6

2.8

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

113

1.15

0.13

3.7

1.6

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

106

0.85

0.13

1.2

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

110

0.82

0.13

1.0

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

237

2425

0.98

0.12

2.5

ug/l

0.7

0.03

130

1295

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

146

1504

0.97

0.12

1.3

ug/l

3.1

3.8

1.66

141

1427

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

158

0.89

0.12

1.9

1.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

181

1.11

0.12

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

278

1.08

0.12

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

278

1.08

0.12

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

728

1.04

0.12

1.1

u/ml

3.1

2.7

0.16

386

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

116

0.86

0.12

1.0

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

108

1117

0.97

0.11

1.6

1.5

nmol/l

0.5

0.09

933

(3028707) Methadone [Presence] in Urine by Screen method

163

1673

0.97

0.11

3.6

3.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

828

1.04

0.11

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

279

1.08

0.11

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

279

1.08

0.11

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

279

1.08

0.11

1.1

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

164

1682

0.97

0.11

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

280

1.07

0.10

1.2

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

125

1.12

0.10

3.4

1.5

—

(3044290) Cell count panel - Cerebral spinal fluid

791

1.04

0.10

1.5

1.6

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

949

1.03

0.10

1.6

1.5

mg/l

461.2

453.0

0.05

900

(4198724)

402

0.94

0.10

1.5

3.3

—

(3015183) Erythrocyte sedimentation rate

269

0.93

0.10

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

193

1.09

0.10

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.11

0.09

1.2

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

164

1.10

0.09

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

298

2935

1.02

0.09

1.4

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

233

1.07

0.09

1.0

u/ml

22.8

6.8

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.11

0.09

1.0

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

1.09

0.08

1.8

1.7

nmol/l

2.0

648787.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

441

0.95

0.08

1.1

mg/l

30.3

38.0

1.44

361

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.07

0.08

1.0

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

204

1.08

0.08

2.5

2.1

umol/l

2.0

1.9

0.16

195

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.05

0.08

1.0

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

304

3084

0.98

0.08

2.2

1.9

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

111

1082

1.03

0.08

1.5

1.3

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.06

0.08

1.1

1.2

—

(40758292) HTLV I+II Ab panel - Serum

0.86

0.07

2.0

1.3

—

(3004451) EKG impression Narrative

1.03

0.07

1.0

1.2

—

(40768806) Pleura Pathology biopsy report

112

0.89

0.07

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

353

1.05

0.07

1.2

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

122

0.90

0.07

1.2

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

167

1.08

0.06

4.3

4.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.88

0.06

3.5

3.4

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

0.86

0.06

1.0

1.2

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

478

0.96

0.06

1.6

1.2

umol/l

6.1

6.6

0.40

446

(3008401) Mugwort IgE Ab [Units/volume] in Serum

116

1185

0.98

0.06

1.0

1.1

u/ml

0.8

1.4

1.02

543

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

128

1.09

0.06

1.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

189

1861

1.02

0.06

4.1

3.2

mmol/l

1.2

0.15

167

1604

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

295

1.05

0.06

1.2

1.1

u/l

1.0

—

120

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

236

1.06

0.06

1.3

1.2

—

(4133840)

109

1.10

0.06

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

182

1846

0.99

0.05

1.4

—

(40757494) Bilirubin.total [Moles/volume] in Blood

129

1.09

0.05

1.3

2.1

—

23.8

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

123

1252

0.98

0.05

1.0

1.1

u/ml

7.9

7.1

0.20

718

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

253

2502

1.01

0.05

2.8

2.7

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

212

0.94

0.05

2.6

3.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

212

0.94

0.05

5.2

6.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

100

1.10

0.05

2.2

2.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

293

0.96

0.05

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

209

2065

1.01

0.05

1.2

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

475

0.97

0.05

1.1

—

1.9

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

159

1.07

0.05

2.5

1.6

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

159

1.07

0.05

3.6

3.0

nmol/l

0.7

0.9

1.58

121

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

110

0.91

0.05

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

110

0.91

0.05

1.0

1.1

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

232

0.95

0.05

1.1

1.6

umol/l

21.9

25.4

0.28

219

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

110

1.09

0.05

1.3

1.1

93.3

103.9

0.67

103

(3025018) Bordetella pertussis Ab [Titer] in Serum

248

1.05

0.05

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

179

1.06

0.05

1.5

1.6

38.1

38.0

0.00

121

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

140

0.93

0.04

1.5

2.1

umol/l

20.4

15.0

0.54

140

(4281824)

209

1.05

0.04

1.2

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

227

2292

0.99

0.04

1.1

titre

798.8

186.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

308

3103

0.99

0.04

1.5

1.6

—

(3028300) Cannabinoids [Presence] in Urine

398

3955

1.01

0.04

2.4

2.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

3431

34341

1.00

0.04

14.1

10.4

40.3

40.4

0.33

2867

28421

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

299

1.04

0.03

1.2

1.1

ratio

1.0

1.1

—

112

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

290

2922

0.99

0.03

1.7

1.8

—

(3000764) Benzodiazepines [Presence] in Urine

395

3926

1.01

0.03

2.4

2.2

—

(40768793) Breast Pathology biopsy report

617

1.02

0.03

1.3

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

797

1.02

0.03

1.0

1.1

u/ml

0.5

0.4

0.12

186

(3022621) pH of Urine by Test strip

202

2037

0.99

0.03

2.6

2.5

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

1.09

0.03

1.0

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

561

0.98

0.03

2.8

2.1

g/l

129.8

132.8

0.39

439

(40768443) Skin Pathology biopsy report

115

1137

1.01

0.02

1.1

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

261

1.03

0.02

1.3

1.1

miu/ml

1297.1

1507.2

0.38

261

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

841

0.99

0.02

1.8

1.6

e6/l

79.9

5342.0

0.65

686

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

349

0.97

0.02

1.4

1.3

—

31.0

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

451

4493

1.00

0.02

2.9

2.4

e6/l

1.1

0.12

269

2422

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1203

12011

1.00

0.02

1.9

1.8

—

(3027008) Opiates [Presence] in Urine

396

3949

1.00

0.01

2.4

2.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

962

1.01

0.01

1.2

1.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

363

1.02

0.01

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

126

0.95

0.00

1.5

1.0

—

(3044927) Protein electrophoresis panel - Urine

146

0.96

0.00

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

294

1.02

0.00

1.2

1.3

mmol/l

2.0

1.8

0.21

275

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

334

1.02

0.00

1.4

1.5

pmol/l

517.4

376.2

0.64

265

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

416

0.99

0.00

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

158

1.01

0.00

1.8

1.5

u/field

1.1

4.4

—

119

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

162

0.99

0.00

1.0

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

115

1.04

0.00

1.0

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

124

0.97

0.00

1.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

174

0.98

0.00

1.8

2.0

u/field

2.0

2.3

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

186

1.02

0.00

1.3

1.2

—

(3001556) Androgen free Index in Serum or Plasma

123

0.98

0.00

1.0

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

161

0.99

0.00

1.3

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

179

1.01

0.00

1.6

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

309

1.00

0.00

1.2

1.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

861

1.00

0.00

1.2

1.1

—

(3016879) Cocaine [Presence] in Urine

364

3643

1.00

0.00

2.5

2.3

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.6

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.91

0.00

2.4

2.5

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

0.0

1.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.0

9.6

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.00

0.00

1.7

1.5

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.2

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

0.0

3.6

—

7.9

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

0.00

0.0

1.0

—

0.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3003771) Antithrombin Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

0.0

1.1

—

91.3

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.91

0.00

1.4

1.8

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

840

1.00

0.00

1.8

1.5

e6/l

16.8

20.4

0.11

654

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.0

1.1

—

215.8

—

(3010937) Rubella virus Ab [Presence] in Serum

0.93

0.00

1.2

1.1

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

0.00

0.0

1.1

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.0

1.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

0.0

3.0

—

(40765096) Chromosome analysis panel by Banding

0.98

0.00

1.5

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

160

1.00

0.00

1.4

1.8

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.0

—

2.9

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.01

0.00

1.6

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.97

0.00

1.2

1.1

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.0

3.8

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

1.1

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.0

1.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

160

1.00

0.00

3.3

1.5

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.98

0.00

1.0

1.1

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.98

0.00

2.6

2.9

mg/l

2.2

3.6

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

0.00

0.0

1.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3042517) Benzodiazepines panel - Urine

0.92

0.00

4.7

2.4

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.0

1.1

—

(3047185) IgG [Mass/volume] in Urine

0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_EMBED_TEETH and mortality.

Females

Parameter	HR [95% CI]	p-value
K11_EMBED_TEETH	1.341 [1.11, 1.62]	0.003
Birth year	0.999 [0.99, 1.01]	0.849

During the follow-up period (1.1.1998 — 31.12.2019), 390 out of 20148 females with K11_EMBED_TEETH died.

Males

Parameter	HR [95% CI]	p-value
K11_EMBED_TEETH	1.447 [1.23, 1.7]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.016

During the follow-up period (1.1.1998 — 31.12.2019), 679 out of 14936 males with K11_EMBED_TEETH died.

Mortality risk

Mortality risk for people of age

years, who have K11_EMBED_TEETH.

N-year risk	Females	Males
1	0.129%	0.248%
5	0.76%	1.574%
10	2.17%	4.223%
15	4.374%	8.045%
20	7.752%	13.53%

Relationships between endpoints

↥

Index endpoint: K11_EMBED_TEETH – Embedded teeth, including avohilmo

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Embedded teeth, including avohilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints